RECRUITINGINTERVENTIONAL

Metacognitive Intervention in Children and Adolescents With ADHD - MiA Study

About This Trial

The aim of the MiA-Study is to address the current lack of effective treatment options to reduce cognitive and physical long-term problems in children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD). Through the use of the Mio-Training, cognitive development will be strengthened and metacognitive thinking and awareness will increase. The MiA-Study is conducted additionally to the Mio-study to evaluate the effectiveness of the Mio-Training specifically within the ADHD population. The Mio-Training for children and adolescence with ADHD includes a combination of cognitive and coordinative training tasks and prospective as well as retrospective metacognitive questions. In a randomized controlled trial, the Mio-Training will be analysed for its efficacy on metacognitive thinking and executive functions. In particular, the investigators are interested in factors that affect the efficacy of the training program such as compliance, age, sex or the severity of the ADHD. This study will give insight into the role of metacognition in cognitive performance and will foster the development of children and adolescents with ADHD in the long-term.

Who May Be Eligible (Plain English)

Who May Qualify: - willing to sign a consent form as documented by signature (see willing to sign a consent form Form) of participants and / or one parent / legal guardian - Age 8-16 years - A diagnosis of ADHD (mild, moderate or severe) - Intelligence \>85 (WISC-V short form) - German or french speaking - Willingness to perform the assessments without the medication (the study visits will take place without ADHD medication) Who Should NOT Join This Trial: - Any other instable neurological condition (e.g. epilepsy) that significantly impairs development - A severe psychiatric disease (e.g., eating disorder) or severe learning disability that significantly impairs development - Known or suspected non-compliance - Inability to follow the procedures of the study, e.g. due to language problems - Enrolment of the investigator, his/her family members, employees and other dependent persons Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * Informed consent as documented by signature (see Informed Consent Form) of participants and / or one parent / legal guardian * Age 8-16 years * A diagnosis of ADHD (mild, moderate or severe) * Intelligence \>85 (WISC-V short form) * German or french speaking * Willingness to perform the assessments without the medication (the study visits will take place without ADHD medication) Exclusion Criteria: * Any other instable neurological condition (e.g. epilepsy) that significantly impairs development * A severe psychiatric disease (e.g., eating disorder) or severe learning disability that significantly impairs development * Known or suspected non-compliance * Inability to follow the procedures of the study, e.g. due to language problems * Enrolment of the investigator, his/her family members, employees and other dependent persons

Treatments Being Tested

BEHAVIORAL

Mio-Training

The Mio-Training aims to increase metacognitive knowledge, teaches mnemonic skills, trains the working memory capacity and coordinative skills to strenghten cognitive development in children and adolescents with ADHD.

Locations (1)

Insespital, University Hospital Bern

Bern, Switzerland